Week Starts with Optimism Regarding Tech Earnings, Tokyo Collaboration: Jan. 26, 2026

Enthusiasm concerning the most eventful earnings week of the season has investors raising exposures to tech shares prior to four of the Magnificent Seven reporting results this Wednesday and Thursday. Wall Street is certainly starting off this Monday on the right foot, as analysts patiently await to hear further about AI initiatives, the pace of investment and expected profits to better gauge if the theme can continue to carry this bull market, which began in 2023. But if not, participants are geared up to keep rotating into the reacceleration trades that benefit disproportionately from rate cuts amidst faster growth, especially as the cyclically oriented benchmarks have outperformed the S&P 500 and Nasdaq 100 substantially year to date. A November Durable Goods beat this morning contributed to improved sentiment, as it featured a pickup in capital expenditures alongside broad transaction strength across components. Meanwhile, Treasuries are rallying as Washington and Tokyo coordinate financial stability efforts related to the Asian country’s currency and surging sovereign borrowing costs. Indeed, the US curve is descending in bull-flattening motion led by duration; however, the potential for White House tolerance of a stronger yen is creaming the greenback, offering a boost to the administration’s onshoring ambitions and to the bottom lines of global corporates. Speculation of intervention in Japan, relatively loose central banks, Trump tariff threats to Canada and rising risks of another government shutdown are extending intense rallies in safe-haven precious metals, as gold and silver march above new milestones of $5,100 and $115, respectively.

Capex Grows for Fifth Consecutive Month

November Durable Goods featured the fifth consecutive month of expanding business investment, signaling ongoing momentum as corporates are poised to take advantage of the 100% first-year depreciation incentives in 2026 for a wide range of capital expenditures as allowed by last year’s passage of the Big Beautiful Bill. The headline growth of 5.3% month over month (m/m) flew past the median estimate of 0.3% and October’s -2.1%. Non-defense purchases excluding aircraft, a proxy for business investment, grew 0.7% m/m, accelerating from the previously reported 0.3%. This report was originally scheduled for late December but was delayed about four weeks by the government shutdown.

No More Cuts Under Powell?

Fixed-income watchers continue to anticipate that the first rate cut of 2026 will occur in June as there’s just a 28% chance that the central bank will reduce its benchmark prior to Chair Powell’s term ending in May. Nonetheless, Wall Street is still eager to hear from the chief this Wednesday following a largely expected pause and the committee’s statement release. Top of mind for investors will be the monetary policy authority’s opinions on labor conditions, inflationary trends and the organization’s stance regarding its level of accommodation or restriction. Meanwhile, observers will also focus on any comments referencing the White House’s pressure campaign to slash borrowing costs expeditiously as well as two separate investigations into Governor Cook and Chair Powell. And subsequent to the January decision, equity traders will have their moment, as Microsoft, Meta and Tesla are geared up to report after the bell. The bull market has been broadening, but with tech now failing to advance for three consecutive months, participants will analyze the results closely for clues that may inform whether we’re in the early, mid or later innings of the AI revolution. An acceleration in capital expenditures amidst growing profit expectations driven by the modern technology would indicate that the ballgame is only beginning; however, a dwindling appetite for devoting billions of dollars to the innovation could signal that its effects are overdone, therefore sparking further cyclical outperformance as folks rotate from the Qs and the S&P to the Dow and Russell.

International Roundup

Biomedical Manufacturing Pulls Down Singapore Output

Singapore’s industrial production recorded its second consecutive m/m contraction in December and the sector’s growth relative to the year-ago period decelerated significantly with bio manufacturing softening, according to the island-city’s Economic Development Board. When compared to November, output sank 13.3%, which while better than the economist consensus estimate for a 15.2% fall, was worse than November’s 7.8% slip. Compared to the last month of 2024, the amount of finished goods was up 8.3%, significantly underperforming the 10.1% estimate and November’s 18.2% year-over-year (y/y) expansion.

For the y/y result, biomedical manufacturing was the biggest headwind, declining 38.8% following 92.2% and 79.1% gains in October and November. Chemicals, furthermore, descended 1.6% while general manufacturing was flat. On an encouraging note, electronics, transport engineering and precision engineering climbed 30.8%, 19.9% and 3.4%. 

Japan Outlook Gets Assist from Consumers, Equities and Job Market

Japan’s Leading Indicator Index climbed 0.1% in November to 109.9 with strengthening consumer sentiment, a November rise in equities and a strong market helping the metric reach the highest level since May 2024. Nevertheless, the upward motion missed the economist consensus estimate for a 0.7% advance and was a deceleration from 0.9% in October. Meanwhile, the Coincident Indicator moved south 1%. The economist consensus anticipated a 0.7% fall following October’s 1.3% decline.